PTRCTDevelopmental neurorehabilitation2019

Short-burst interval treadmill training walking capacity and performance in cerebral palsy: a pilot study.

Kristie F Bjornson, Noelle Moreau, Amy Winter Bodkin

PMID 29658831

WHAT IT FOUND

After 20 short-burst treadmill sessions, 12 children with cerebral palsy walked faster and more in daily life, with gains partly kept at 6 weeks.

No control group means the training effect is uncertain.

Key findings

01Walking capacity measures were better immediately after training and at 6 weeks.

02Accelerometer-measured daily walking was higher after training and at 6 weeks.

03Parent-reported physical activity was higher at 6 weeks, and recreation participation was higher after training.

STILL TO COME

How it was doneWhat they foundWhat it means for PTs

Read the rest of this summary

You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.

Already have one?

What it does not show

No control group, so changes cannot be separated from usual therapies or other factors not controlled by the study. The sample was only 12 children with spastic diplegia, GMFCS levels II and III, ages 5 to 12, so it does not address children with other CP types, higher GMFCS levels, or older children. Walking capacity was measured by an unblinded examiner, although daily walking performance used an accelerometer. The comparison of 5 sessions per week versus 2 sessions per week was exploratory and small, so frequency findings need caution. Parent-reported physical activity, participation, fatigue, and pain outcomes were exploratory. One child could not train up to a full 30 minutes in a 60-minute session, so the protocol may not be tolerated by all children. Participants could continue ongoing therapies and medications, so the contribution of any single treatment cannot be separated.

The easy way to misread this

Do not read the gains in 12 children as proof that short-burst treadmill training alone caused them. There was no control group, children could continue usual therapies, and the dose-frequency comparison was exploratory.

Read it on PubMed →